RE: VAL2 Jun 2020 12:34
Hi Freddie
After reading it again the best bit of todays rns is........(of a short term experimental plan) as in below.
Subject to successful out-licencing, ValiRx will receive 40% of all licensing income generated. The collaboration addresses an emergent and immediate unmet medical need, and details the commencement of a short term experimental plan, with the agreement covering a maximum of two years.